Antithrombins: Indirect Inhibitors (e.g. Enoxaparin)
|
Antithrombins: Indirect Inhibitors (e.g. Enoxaparin) |
|
Overviews of Enoxaparin Low Molecular wt Heparinoids in ACS TESMA: TIMI ESSENCE meta analysis Cost effectiveness in ESSENCE |
UA / Non STEMI Trials NICE 1: National Investigators Collaborating on Enoxaparin 1 NICE 3: National Investigators Collaborating on Enoxaparin 3 NICE 4: National Investigators Collaborating on Enoxaparin 4 STEEPLE Intravenous (IV) enoxaparin vs IV unfractionated heparin (UFH) in patients undergoing nonemergent PCI SYNERGY Safety and efficacy of enoxaparin compared with unfractionated heparin (UFH) in high-risk patients with non-ST-segment elevation acute coronary syndromes |
STEMI Trials ExTRACT TIMI 25: Enoxaparin vs UHF in the management of STEMI patients treated with a fibrinolytic PCI ExTract TIMI 25: Enox superior to UFH among pts undergoing PCI after lysis. Presented by Dr. C. Michael Gibson |